Kaishima, Misato
Ito, Junichi
Takahashi, Kentaro
Tai, Kenji
Kuromitsu, Junro
Bun, Shogyoku
Ito, Daisuke
Funding for this research was provided by:
the Japan Agency for Medical Research and Development (JP17pc0101006, JP17pc0101006, JP17pc0101006, JP17pc0101006, JP17pc0101006, JP17pc0101006, JP17pc0101006)
Article History
Received: 13 February 2025
Accepted: 3 May 2025
First Online: 22 May 2025
Declarations
:
: The study design and protocol were approved by the Certified Review Board of Keio University (#N20170237) and adhered to the principles of the Declaration of Helsinki. All participants (plus their proxies as needed) provided written informed consent for participation in the study. The study was registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR; , ID# UMIN000032027) on March 31, 2018, and the Japan Registry of Clinical Trials (jRCT; , ID# jRCTs031180225) on March 11, 2019.
: Not applicable.
: MK, JI, KTakahashi, KTai, and JK are employees of Eisai. DI has received honorariums from Daiichi Sankyo, Nihon Medi-Physics, Kowa, PDRadiopharma, and Eisai. No other relationships or activities that could have influenced the submitted work are reported. SB declares no competing interests.